Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | |
| Operating Expenses | 0 | 0 | 202 |
| Operating Income | N/A | N/A | -202 |
| Interest Expense | 3 | 0 | 0 |
| Other Income | 3 | 0 | 18 |
| Pre-tax Income | 0 | 0 | -184 |
| Net Income Continuous | N/A | N/A | -205 |
| Net Income Discontinuous | N/A | N/A | -391 |
| Net Income | $N/A | $N/A | $-597 |
| EPS Basic Total Ops | -2.80 | N/A | -3.40 |
| EPS Basic Continuous Ops | N/A | N/A | -1.00 |
| EPS Basic Discontinuous Ops | N/A | N/A | -2.20 |
| EPS Diluted Total Ops | -2.80 | N/A | -3.40 |
| EPS Diluted Continuous Ops | N/A | N/A | -1.00 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -2.20 |
| EBITDA(a) | $N/A | $N/A | $-202 |